News and Press Releases 10/2/2002 SLIL Biomedical Announces Publication of Study on its Proprietary ‘Sequential Pathogenesis’ Technology in October Issue of Cancer Research 10/1/2002 Macrophages from Human Lymphoma Patients Cause Mouse Lymphoma in Mice, UCSF Study FInds 6/19/2002 SLIL Biomedical Announces the Appointment of James E. Rurka as President and CEO; Dr. Bradley Brown named to Board of Directors 11/26/2001 SLIL Closes Licensing and Equity Deal with PPD 10/20/2001 Phase I Clinical Trial to Commence on SLIL Cancer Drug, SL11047 5/2/2001 IND filed on new AIDS-cancer drug from SLIL 10/11/2000 SLIL Biomedical announces deal with Elanco Animal Health 7/31/2000 SLIL Biomedical adds George Wilding to its Scientific Advisory Board 7/31/2000 former FDA commissioner, Dr. Jere Goyan elected to board of directors of SLIL Biomedical 1/1/2000 SLIL Biomedical appoints Dr. Janice LeCocq to Board of Directors